Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01328899
Other study ID # CLN0011
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received
Last updated
Start date December 2009
Est. completion date January 2013

Study information

Verified date July 2021
Source Boston Scientific Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a multicenter single arm open label study. The primary objective is to evaluate the safety and effectiveness of the Lung Volume Reduction Coil (LVRC) for the treatment of patients with emphysema in multiple centers.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date January 2013
Est. primary completion date January 2013
Accepts healthy volunteers No
Gender All
Age group 35 Years and older
Eligibility Inclusion Criteria: - Greater than or equal to 35 years of age - bilateral heterogenous emphysema - Patient has stopped smoking for a minimum of 8 weeks - Read, understood and signed the Informed consent form Exclusion Criteria: - Patient has a history of recurrent significant respirator infection - Patient has an inability to walk > 140 meters - Patient has evidence of other disease that may compromise survival such as lung cancer, renal failure, etc - Patient is pregnant or lactating - Patient has clinical significant bronchiectasis - Patient has had previous LVR surgery, lung transplant or lobectomy - Patient has been involved in other pulmonary drug studies within 30 days prior to this study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Lung Volume Reduction Coil (LVRC) (PneumRx's)
Lung Volume Reduction Coil

Locations

Country Name City State
France CHU de Nice - Hospital Pasteur Nice
France Gaetan Deslee Reims
France CHRU de Strasbourg-NHC Strasbourg
Germany Campus Charite Mitte Berlin
Germany Klinikum Donaustauf Donaustauf
Germany Asklepios Gauting
Germany Thoraxklinik Heidelberg
Germany Lungenklinik Hemer
Germany Krankenhaus von Roten Kreuz Stuttgart
Germany UKT University Hospital Teubingen
Netherlands University Medical Center Groningen Groningen

Sponsors (2)

Lead Sponsor Collaborator
Boston Scientific Corporation PneumRx, Inc.

Countries where clinical trial is conducted

France,  Germany,  Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary St. George's Respiratory Questionnaire Symptomatic improvement in St. George's Respiratory Questionnaire (SGRQ) from Baseline 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05825261 - Exploring Novel Biomarkers for Emphysema Detection
Completed NCT02999685 - Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients N/A
Completed NCT02914340 - REACH SVS Control Patient Cross-Over Study N/A
Completed NCT02232841 - Electrical Impedance Imaging of Patients on Mechanical Ventilation N/A
Completed NCT02238327 - Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes
Completed NCT01615484 - Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability N/A
Withdrawn NCT01908933 - Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema Phase 3
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT01710449 - Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen Phase 1
Suspended NCT00523094 - Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure N/A
Completed NCT00475007 - Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema N/A
Recruiting NCT00129350 - Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation Phase 1
Completed NCT01953523 - Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions N/A
Completed NCT00000621 - Feasibility of Retinoic Acid Treatment in Emphysema (FORTE) Phase 2
Completed NCT00005292 - Alpha1-antitrypsin Deficiency Registry N/A
Recruiting NCT04537182 - Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema N/A
Active, not recruiting NCT02713347 - Advancing Symptom Alleviation With Palliative Treatment N/A
Recruiting NCT04302272 - STRIVE Post-Market Registry Study
Completed NCT04435327 - Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
Completed NCT03636347 - A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. Phase 2